One study in pediatric patients with respiratory infections also showed there was higher glucose metabolism in the lungs compared to control; oral treatment with BEZ235 (a putative PI3 K/mTOR inhibitor) decreased glycolysis and reduced virus replication which resulted in decreased mortality in the mouse model of influenza infection [29]. Here, MTOR is linked to respiratory tract infectious disorder.